-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Precision Biosciences Receives Favorable Type C Feedback From FDA

Reuters · 01/06/2023 07:15
BRIEF-Precision Biosciences Receives Favorable Type C Feedback From FDA

- Precision BioSciences Inc DTIL.O:

  • PRECISION BIOSCIENCES RECEIVES FAVORABLE TYPE C FEEDBACK FROM THE FDA ON THE COMPANY’S CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) STRATEGIES FOR LATE-STAGE DEVELOPMENT OF AZERCABTAGENE ZAPRELEUCEL, ITS LEAD ALLOGENEIC CAR T CLINICAL CANDIDATE

  • PRECISION BIOSCIENCES INC - FDA FEEDBACK SIGNALS COMPANY'S CMC PLANS SHARED ARE IN ALIGNMENT WITH AGENCY REQUIREMENTS AND EXPECTATIONS

Source text for Eikon: ID:

Further company coverage: DTIL.O


((Reuters.Briefs@thomsonreuters.com;))